Video
+1
Mar 17, 2026
•
2 min read
How Indira Paharia of VIBEcare Is Rethinking Behavioral Health Delivery
StartUp Health community member Indira Paharia, PsyD, explains why behavioral health belongs in primary care, how VIBEcare scales evidence-based support virtually, and why treating mental health lowers total healthcare costs.
Video
+1
Mar 16, 2026
•
2 min read
Expert Advice & Passionate Partnerships - Guillaume Blivet's Health Transformer Experience
Guillaume Blivet of REGEnLIFE shares how being part of the StartUp Health Alzheimer’s Moonshot community has helped accelerate the company’s mission to develop a safe, non-invasive brain-gut neuromodulation therapy for Alzheimer’s disease. From expert guidance to meaningful partnerships, he explains why collaboration is essential to transforming the future of Alzheimer’s care.
Video
+1
Mar 13, 2026
•
2 min read
Cognimark: Meet the Founder Turning Personal Experience Into AI-Powered Dementia Innovation
After watching his own family struggle to navigate late-stage Alzheimer’s, StartUp Health community member Andrew Lu, CEO & Co-founder of Cognimark, set out to build an AI-powered neurology copilot that helps clinicians detect dementia earlier and guide patients through a fragmented care journey with greater clarity and speed.
Video
+1
Mar 12, 2026
•
2 min read
How SynchNeuro Is Using Brain Data to Personalize Metabolic Health
StartUp Health community member Dr. Casey Halpern explains how SynchNeuro is decoding brain signals to create a discreet, affordable, non-invasive glucose monitor that could help millions better understand metabolism, personalize food choices, and prevent Type 2 diabetes.
Insights
+1
Mar 10, 2026
•
9 min read
BCI & AI Platforms Drive a Global Health Innovation Funding Week | StartUp Health Insights: Week of Mar 10, 2026
This week's health tech funding spans brain-computer interfaces, Alzheimer's therapeutics, vision restoration, senior care AI, sleep health, value-based care, advanced therapy delivery, AI workforce automation, antibody design, biosensing wearables, revenue cycle management, and preventive diagnostics, with deals spanning the United States, South Korea, Wales, Switzerland, India, the UAE, and Italy.
Insights
+1
Mar 3, 2026
•
9 min read
Mental Health, Value-Based Care, and Brain Health Anchor a Global Funding Week | StartUp Health Insights: Week of Mar 3, 2026
This week's global health innovation funding highlights major investments in mental and behavioral health, brain health and neurotechnology, value-based care infrastructure, and AI-powered platforms across drug discovery, virtual care, cognitive assessment, and medtech commercialization. From nine-figure raises in the US to deals spanning India, Europe, and the UK, investors continue to back companies building smarter care delivery, precision therapeutics, and scalable health operations.
Video
+1
Feb 25, 2026
•
2 min read
Preparing for US Expansion - Dr. David Berron's Health Transformer Experience
StartUp Health community member David Berron, PhD, shares how participation in the Alzheimer’s Health Moonshot Community has been invaluable as neotiv prepares for US expansion. The community’s support is helping the team identify the right partners and pathways to bring early cognitive assessment to more people worldwide.
Insights
+1
Feb 24, 2026
•
8 min read
AI Drug Discovery and Care Infrastructure Drive a Global Funding Week | StartUp Health Insights: Week of Feb 24, 2026
This week’s global health innovation funding highlights strong momentum in AI-powered drug discovery, sleep and neurotherapy, payment integrity, and care delivery infrastructure. From major raises in the U.S. and Europe to grant-backed efforts improving access to essential medicines in low- and middle-income countries, investors continue to back platforms reshaping how care is discovered, paid for, and delivered worldwide.
Video
+1
Feb 20, 2026
•
2 min read
Alamar Biosciences Is Advancing Early Disease Detection
StartUp Health community member Alamar Biosciences focuses on advancing early disease detection through a high-sensitivity platform for protein biomarker analysis. Their brain-specific assays enable detection of brain-derived proteins in blood, previously only found in cerebrospinal fluid (CSF). The company has launched a multiplex CNS panel for nerve regeneration and inflammation biomarkers, helping to detect Alzheimer's disease earlier. Looking ahead, Alamar aims to expand into clinical applications and collaborate with partners to scale their technology.
